Bad Blood : Secrets and Lies in a Silicon Valley Startup

Resumen del libro

A New York Times bestseller. Winner of the Financial Times/McKinsey Business Book of the Year Award. 'Chilling .

. . Reads like a West Coast version of All the President's Men.' New York Times Book ReviewThe full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than 9 billion, putting Holmes's worth at an estimated 4.7 billion. There was just one problem: The technology didn't work.

In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley. Now to be adapted into a film, with Jennifer Lawrence to star.

Biografía del autor

Periodista franco-estadounidense que trabaja para The Wall Street Journal desde 1999 desde distintas ciudades como Bruselas, París y Nueva York. En 2008 fue nombrado jefe de la Oficina de Salud y Ciencia en Nueva York. Junto a un equipo del Journal, Carreyrou ganó el Pulitzer en 2003 por una serie de historias que expusieron varios escándalos corporativos en Estados Unidos y 2015, junto al Premio Gerald Loeb de Investigación, por Medicare Unmasked. También ha ganado los Premios Junior y Senior Peter R. Weitz del German Marshall Fund y el Premio George Polk, categoría Información Financiera.